Translational Interventional Electrophysiology Laboratory, Mayo Clinic/St. Marys Campus, Rochester, MN (A.S., M.E.R., H.I.L., S.H., S.W., H.K., L.K.N., K.D.P., K.H.M., D.L.P.).
Department of Radiation Oncology, Mayo Clinic, Rochester, MN (A.J.D., J.J.K., J.T.C., M.G.H.).
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008838. doi: 10.1161/CIRCEP.120.008838. Epub 2020 Sep 13.
Proton beam therapy offers radiophysical properties that are appealing for noninvasive arrhythmia elimination. This study was conducted to use scanned proton beams for ablation of cardiac tissue, investigate electrophysiological outcomes, and characterize the process of lesion formation in a porcine model using particle therapy.
Twenty-five animals received scanned proton beam irradiation. ECG-gated computed tomography scans were acquired at end-expiration breath hold. Structures (atrioventricular junction or left ventricular myocardium) and organs at risk were contoured. Doses of 30, 40, and 55 Gy were delivered during expiration to the atrioventricular junction (n=5) and left ventricular myocardium (n=20) of intact animals.
In this study, procedural success was tracked by pacemaker interrogation in the atrioventricular junction group, time-course magnetic resonance imaging in the left ventricular group, and correlation of lesion outcomes displayed in gross and microscopic pathology. Protein extraction (active caspase-3) was performed to investigate tissue apoptosis. Doses of 40 and 55 Gy caused slowing and interruption of cardiac impulse propagation at the atrioventricular junction. In 40 left ventricular irradiated targets, all lesions were identified on magnetic resonance after 12 weeks, being consistent with outcomes from gross pathology. In the majority of cases, lesion size plateaued between 12 and 16 weeks. Active caspase-3 was seen in lesions 12 and 16 weeks after irradiation but not after 20 weeks.
Scanned proton beams can be used as a tool for catheter-free ablation, and time-course of tissue apoptosis was consistent with lesion maturation.
质子束治疗提供了非侵入性消除心律失常的物理特性。本研究旨在使用扫描质子束消融心脏组织,研究电生理结果,并使用粒子疗法在猪模型中描述病变形成过程。
25 只动物接受了扫描质子束照射。在呼气末屏气时采集心电图门控计算机断层扫描。对结构(房室结或左心室心肌)和危险器官进行轮廓勾画。在呼气时将 30、40 和 55Gy 的剂量分别输送到完整动物的房室结(n=5)和左心室心肌(n=20)。
本研究通过在房室结组中进行起搏器询问、在左心室组中进行时程磁共振成像以及对大体和显微镜病理学显示的病变结果进行相关性分析,跟踪了手术成功率。进行蛋白质提取(活性半胱天冬酶-3)以研究组织细胞凋亡。40 和 55Gy 的剂量导致房室结处的心脏冲动传播减慢和中断。在 40 个接受左心室照射的靶标中,所有病变在 12 周后均在磁共振上被识别,与大体病理学结果一致。在大多数情况下,病变大小在 12 至 16 周之间趋于平稳。在照射后 12 和 16 周可见活性半胱天冬酶-3,但在 20 周后未见。
扫描质子束可用作无导管消融的工具,组织细胞凋亡的时程与病变成熟一致。